The reason for the variation of the pain is unknown, although it seems the modulation of the proposed central pain amplification may be mediated by NMDA receptors and nerve growth factor (NGF) (Petersel et al., 2010), as well as cognitive and emotional comorbidities such as depression (Smith et al., 2011). This evidence concerns the gene NGF and depressive symptom measurement.